国际肿瘤学杂志››2012,Vol. 39››Issue (12): 886-888.

• 综述 •上一篇下一篇

GRIM-19基因与肿瘤

邵玉佩, 万小云

  1. 310006杭州,浙江大学医学部附属妇产科医院肿瘤科
  • 出版日期:2012-12-08发布日期:2012-11-15
  • 通讯作者:通信作者:万小云,E-mail: wanxy@zju.edu.cn E-mail:wanxy@zju.edu.cn
  • 基金资助:

    浙江省医药卫生betway必威亚洲 基金资助项目(2010KYA130)

GRIM-19 gene and tumor

SHAO Yu-Pei, WAN Xiao-Yun

  1. Department of Oncology,Women’s Hospital,School of Medicine,Zhejiang University,Hangzhou 310006,China
  • Online:2012-12-08Published:2012-11-15
  • Contact:Corresponding author: WAN Xiao-yun, E-mail: wanxy@zju.edu.cn E-mail:wanxy@zju.edu.cn

摘要:干扰素、维甲酸联合应用诱导的细胞凋亡相关基因(GRIM)为一组基因,GRIM-19是其核心基因之一。研究显示多种肿瘤中均存在GRIM-19表达的缺失或者降低,表明该基因可能是抑癌基因,并可能成为抗肿瘤药物治疗的重要靶点。

关键词:细胞凋亡,基因,肿瘤抑制,STAT3转录因子

Abstract:Genes associated with retinoid-interferon mortality(GRIM) are a group of genes, and GRIM-19 is one of the core genes. Studies have found that GRIM-19 is down-regulated in many types of tumors, and may be a new type of tumor suppressor and a new target for chemotherapy in tumors.

Key words:Apoptosis,Genes, tumor suppressor,STAT3 transcription factor